PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...
Read more
Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...
Read more
At the turn of the 21st century, scientists Robert Langreth and Michael Waldholz posited a new idea: What if...
Read more
Becky Schultz speaks with founder and CEO of Transient Plasma Systems, Dan Singleton, about the company’s plasma-based aftertreatment and...
Read more
Linnaeus Therapeutics announced that the FDA has granted orphan drug designation for LNS8801 for the treatment of patients with...
Read more
MemVerge announced that Jeffrey Wang has been named Vice President of Engineering. With decades of software-defined infrastructure experience across...
Read more
Alex Andrianopoulos, chief R&D officer at Kairos Ventures, said: “The combination of AI with automation will revolutionize and exponentially...
Read more
Applaud Medical announced the appointment of industry veteran Paul Molloy as CEO. The company has also added Molloy to...
Read more
MemVerge Memory Machine™ is the first software-defined Compute Express Linkä (CXLä) memory management solution to offer support for the...
Read more
A new trial sponsored by Axial Therapeutics will test whether a medication that targets gut bacteria can also improve...
Read more